Multi-center Analysis of Outcomes Data on Use of Delcath CHEMOSAT in the Treatment of ICC to be Published in European Radiology
04 sept. 2018 08h00 HE
|
Delcath Systems, Inc.
NEW YORK, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver,...
Delcath Systems to Present at the 8th Annual LD Micro Invitational
29 mai 2018 08h30 HE
|
Delcath Systems, Inc.
NEW YORK, May 29, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTHD), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced...
Bile Duct Cancer (Cholangiocarcinoma) Treatment Market to show Incremental Opportunity of US$ 144.2 Mn by 2025 - Persistence Market Research
21 déc. 2017 03h32 HE
|
Persistence Market Research
New York City, NY, Dec. 21, 2017 (GLOBE NEWSWIRE) -- Persistence Market Research(PMR) forecasts the global bile duct cancer treatment market to grow from about US$ 168 Mn in 2017 to about US$ 312 Mn...